PUBLICATION

Erratum to: Zebrafish phenotypic screen identifies novel Notch antagonists

Authors
Velaithan, V., Okuda, K.S., Ng, M.F., Samat, N., Leong, S.W., Faudzi, S.M., Abas, F., Shaari, K., Cheong, S.C., Tan, P.J., Patel, V.
ID
ZDB-PUB-170212-8
Date
2017
Source
Investigational new drugs : (Other)
Registered Authors
Okuda, Kazuhide Shaun
Keywords
none
MeSH Terms
none
PubMed
28185040 Full text @ Invest New Drugs
Abstract
The authors would like to note that in the original online first version of this article, the symbol ɣ is missing from the text where ɣ-secretase is stated. Also, labels to figures in the Results section should be “CYCLIN D1 levels were also reduced in a similar dose dependent manner while those of HES1 and NOTCH1 (shown by densitometry in Figure S6c) were marginally reduced and remained unaffected, respectively (Fig. 5d)” and “Also, we were able to show as mentioned earlier, that EDD3 treatment resulted in decreased CYCLIND1 levels and induction of p27KIP1 (Figure S8g)”. Subtitle in the Result section should be “Identification of 3 novel compounds with potential anti-Notch activity in zebrafish embryos” and ‘EDD3 inhibits proliferation and cell cycle progression of ORL-150 cells’. The original article was corrected
Errata / Notes
Erratum to Zebrafish phenotypic screen identifies novel notch antagonists
Genes / Markers
Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping